1/31/2008

GE Healthcare and Germany's Fraunhofer Institut für Toxikologie und Experimentelle Medizin agreed to a new molecular-imaging collaboration, according to a GE news release. The two aim to develop new molecular-imaging methods to use to develop treatments for lung and liver cancers.

Related Summaries